For those not steeped in medical vernacular, JAMA is the Journal of the American Medical Association. As the most widely circulated medical journal in the world, JAMA is also among the most respected. Its peer-review process relies on over 3,500 reviewers from more than 40 countries. Simply put, JAMA is the gold standard for medical journals; it is to physicians what the Wall Street Journal is to CEOs.
Dr. Milan Moore – a longtime member of our clinical faculty and a world-renowned orthopedic surgeon – recently noted that an entire issue of JAMA was dedicated to covering the promise of, and exciting developments within, the burgeoning field of genomics.
It’s not exactly light reading, but the content is powerful stuff. Any Market American who plans to call on healthcare practitioners to discuss the opportunities available through nutraMetrix® and Gene SNP™ would be wise to familiarize themselves with this issue; its value as a marketing tool is immeasurable since the information comes from independent, peer-reviewed resources and is published by one of the most respected medical authorities out there.
I know what you’re saying: “But I can’t afford a subscription to JAMA!” Well, with just a bit of Googling, you’ll be happy to know that much of the issue is available online and at no cost. The issue in question can be found here. Two articles have particular importance to the study of genes & nutrition:
“The Genome Gets Personal – Almost”
“Genomic Profiles for Disease Risk: Predictive or Premature?”
Now that’s news you can use!
10/29/2008
Subscribe to:
Post Comments (Atom)
1 comments:
Any updates on getting the ok for Gene SNP's in New York State? My HP prospects don't even want to talk about it until I can tell them when it will be a reality here.
Post a Comment